Columbia Neurologist Lawrence S. Honig, MD, PhD comments about the new Alzheimer's blood testing study and how its findings could be useful, but up to a point.
Dr. Miguel Arce Rentería, a neuropsychologist at Columbia University, comments that treatment that focuses on social issues may hold off the worst of Alzheimer’s Disease for years.
Neuropsychologist Victoria M. Leavitt, PhD is featured in three EveryDay Health podcasts about recognizing and treating patients with mild cognitive impairment.
Education may reduce the risk of cognitive decline associated with the APOE e4 gene—the biggest genetic risk factor for late-onset Alzheimer’s disease—in older non-Hispanic black people.
